Anna Rita Fetoni Selected Research

Noise-Induced Hearing Loss (Acoustic Trauma)

7/2021	Noise-Induced Cochlear Damage Involves PPAR Down-Regulation through the Interplay between Oxidative Stress and Inflammation.
9/2020	Anti-oxidant and anti-inflammatory effects of caffeic acid: in vivo evidences in a model of noise-induced hearing loss.
1/2019	Targeting dysregulation of redox homeostasis in noise-induced hearing loss: Oxidative stress and ROS signaling.
9/2018	Anodal transcranial direct current stimulation affects auditory cortex plasticity in normal-hearing and noise-exposed rats.
1/2018	Pioglitazone Represents an Effective Therapeutic Target in Preventing Oxidative/Inflammatory Cochlear Damage Induced by Noise Exposure.
7/2014	Time evolution of noise induced oxidation in outer hair cells: role of NAD(P)H and plasma membrane fluidity.
1/2014	Grafting and early expression of growth factors from adipose-derived stem cells transplanted into the cochlea, in a Guinea pig model of acoustic trauma.
2/2013	Noise-induced hearing loss (NIHL) as a target of oxidative stress-mediated damage: cochlear and cortical responses after an increase in antioxidant defense.
4/2012	Efficacy of different routes of administration for Coenzyme Q10 formulation in noise-induced hearing loss: systemic versus transtympanic modality.
1/2012	A new oral otoprotective agent. Part 1: Electrophysiology data from protection against noise-induced hearing loss.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Rita Fetoni Research Topics

Disease

14	Hearing Loss (Hearing Impairment) 10/2022 - 01/2002
13	Noise-Induced Hearing Loss (Acoustic Trauma) 07/2021 - 06/2006
10	Ototoxicity 10/2022 - 01/2003
5	Inflammation (Inflammations) 01/2022 - 08/2014
4	Sensorineural Hearing Loss 10/2022 - 01/2002
4	Tinnitus 01/2022 - 07/2010
3	Neoplasms (Cancer) 01/2022 - 01/2020
2	Deafness (Deaf Mutism) 10/2022 - 01/2020
2	Eosinophilia 06/2015 - 08/2014
2	High-Frequency Hearing Loss 03/2004 - 01/2003
1	Vertigo (Positional Vertigo) 01/2022
1	Thyroid Diseases (Thyroid Disease) 01/2022
1	Benign Paroxysmal Positional Vertigo 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Hypothyroidism 01/2022
1	Acoustic Neuroma (Acoustic Neurinoma) 01/2022
1	Otitis Media 01/2021
1	Otitis Media with Effusion 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Cognitive Dysfunction 01/2021
1	Neuroinflammatory Diseases 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Neuroblastoma 01/2020
1	Wounds and Injuries (Trauma) 01/2015
1	Allergic Rhinitis 08/2014
1	Polyps 08/2014
1	Rhinitis 08/2014
1	Rhinosinusitis 08/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2009
1	Body Weight (Weight, Body) 03/2004
1	Systemic Vasculitis 05/2003
1	Vasculitis (Vasculitides) 01/2002

Drug/Important Bio-Agent (IBA)

11	AntioxidantsIBA 01/2022 - 06/2006
6	Cisplatin (Platino)FDA LinkGeneric 10/2022 - 08/2003
6	Pharmaceutical PreparationsIBA 01/2022 - 03/2004
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 02/2009
5	coenzyme Q10 (CoQ10)IBA 07/2021 - 02/2009
4	Free RadicalsIBA 01/2020 - 01/2003
3	PlatinumIBA 10/2022 - 01/2020
3	CurcuminIBA 01/2022 - 01/2020
3	PolyphenolsIBA 01/2022 - 01/2020
3	ferulic acid (sodium ferulate)IBA 09/2020 - 04/2011
2	AntibodiesIBA 01/2022 - 05/2003
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2021 - 04/2017
2	alpha-Tocopherol FDA Link 03/2004 - 01/2003
2	Gentamicins (Gentamicin)FDA LinkGeneric 03/2004 - 01/2003
1	Platinum Compounds (Compounds, Platinum)IBA 10/2022
1	Carboplatin (JM8)FDA LinkGeneric 10/2022
1	antineoplaston A10 (A 10)IBA 01/2022
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2022
1	Thyroglobulin FDA Link 01/2022
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2022
1	Vascular Endothelial Growth Factor CIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Iodide Peroxidase (Deiodinase)IBA 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2021
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 07/2021
1	ElementsIBA 07/2021
1	Styrene (Styrol)IBA 01/2021
1	Coumaric AcidsIBA 09/2020
1	phenolic acidIBA 09/2020
1	caffeic acidIBA 09/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	biliverdin reductaseIBA 01/2020
1	Celecoxib (Celebrex)FDA Link 01/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	ConnexinsIBA 01/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2020
1	Connexin 26IBA 10/2018
1	Pioglitazone (Actos)FDA Link 01/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 06/2015
1	Chemokine CCL26IBA 08/2014
1	N 30IBA 08/2014
1	Chemokine CCL24IBA 08/2014
1	NAD (NADH)IBA 07/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2014
1	SolutionsIBA 01/2012
1	SalicylatesIBA 07/2010
1	Quinine (Quinson)FDA Link 07/2010
1	UbiquinoneIBA 02/2009
1	idebenoneIBA 06/2006
1	Tiopronin (Thiola)FDA Link 09/2004
1	Corn Oil (Oil, Corn)IBA 03/2004
1	AminoglycosidesIBA 03/2004
1	Free Radical ScavengersIBA 01/2003
1	AutoantibodiesIBA 01/2002
1	anti-endothelial cell antibodyIBA 01/2002

Therapy/Procedure

5	Therapeutics 10/2022 - 01/2003
2	Drug Therapy (Chemotherapy) 10/2022 - 01/2022
1	Rehabilitation 03/2022
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2022
1	Cochlear Implants (Cochlear Implant) 01/2022
1	Radiotherapy 01/2022
1	Transcranial Direct Current Stimulation 09/2018